ALB and Sepsis: A pooled analysis of primary outcome mortality data of sepsis patients treated with human albumin in SAFE (Finfer et al., 2011), ALBIOS(Caironi et al., 2014), and EARSS (Charpentier, 2011) studies, confirming that albumin treatment could dramatically decrease mortality in SS or sepsis patients (Wiedermann and Joannidis, 2014).